Cargando…

Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone

Bipolar disorder is a debilitating, and chronic condition in adolescents. The rate of diagnosis and treatment is increasing in adolescents despite considerable controversy regarding criteria for diagnosis. Atypical antipsychotics have been studied extensively for adult and adolescent bipolar disorde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Afshan A, Strawn, Jeffrey R, Croarkin, Paul E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915792/ https://www.ncbi.nlm.nih.gov/pubmed/24600269 http://dx.doi.org/10.2147/AHMT.S7586

Ejemplares similares

Ziprasidone in the treatment of mania in bipolar disorder
por: Nicolson, Stephen E, et al.
Publicado: (2007)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
por: Bowden, Charles L
Publicado: (2011)

Commentary: Treatment failure and success: a commentary on defining and treating pediatric treatment‐resistant depression – reflections on Dwyer et al. (2020)
por: Strawn, Jeffrey R., et al.
Publicado: (2020)

Acne caused by ziprasidone in a young patient with bipolar disorder: A case report
por: Yuan, Yiwen, et al.
Publicado: (2022)

Ziprasidone as Adjunctive Therapy in Severe Bipolar Patients Treated with Clozapine
por: Bartolommei, Natalia, et al.
Publicado: (2014)

Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
por: Penders, Thomas M, et al.
Publicado: (2013)

Ziprasidone in the Treatment of Delusional Parasitosis
por: Contreras-Ferrer, P., et al.
Publicado: (2012)

Historical Underpinnings of Bipolar Disorder Diagnostic Criteria
por: Mason, Brittany L., et al.
Publicado: (2016)

Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

Bipolar disorders: treatment options and patient satisfaction
por: Bowden, Charles, et al.
Publicado: (2006)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?
por: Mattei, Chiara, et al.
Publicado: (2011)

Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents
por: Strawn, Jeffrey R., et al.
Publicado: (2023)

Repetitive Transcranial Magnetic Stimulation for Generalized Anxiety Disorder: A Systematic Literature Review and Meta-Analysis
por: Parikh, Tapan K, et al.
Publicado: (2021)

Emerging treatment options for myelofibrosis: focus on pacritinib
por: Chow, Vivian, et al.
Publicado: (2016)

Emerging options for the treatment of melanoma – focus on ipilimumab
por: Roddie, Claire, et al.
Publicado: (2014)

Emerging Treatment Options for Myelofibrosis: Focus on Anemia
por: Sastow, Dahniel, et al.
Publicado: (2023)

Neurocognitive impairment and evidence-based treatment options in Bipolar disorder
por: Fountoulakis, Konstantinos N.
Publicado: (2020)

Evidence review and clinical guidance for the use of ziprasidone in Canada
por: Gardner, David M, et al.
Publicado: (2013)

Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation
por: Seewoo, Bhedita J, et al.
Publicado: (2022)

Emerging treatment options for ovarian cancer: focus on rucaparib
por: Mariappan, Lavanya, et al.
Publicado: (2017)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Ko, Young-Hoon, et al.
Publicado: (2014)

Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department
por: McDowell, Marc, et al.
Publicado: (2019)

A Case Report of Priapism Caused by Ziprasidon
por: Karamustafalioglu, Nesrin, et al.
Publicado: (2013)

MON-675 Ziprasidone Induced Diabetic Ketoacidosis
por: Thanikonda, Varshitha, et al.
Publicado: (2020)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

Bipolar depression: a review of treatment options
por: Levenberg, Kate, et al.
Publicado: (2022)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin, Nefize, et al.
Publicado: (2020)

Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study
por: Jangro, William C, et al.
Publicado: (2009)

Efficacy and Tolerability of Ziprasidone Use in Children and Adolescents, a Systemic Review and Meta Analysis
por: Wadhwa, A., et al.
Publicado: (2022)

Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
por: Rizzoli, Paul B
Publicado: (2014)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts, Rona Jeannie, et al.
Publicado: (2016)

Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents
por: Kirino, Eiji
Publicado: (2014)

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders
por: Kutcher, Stan, et al.
Publicado: (2005)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
por: Shi, Hui, et al.
Publicado: (2022)

PM395. The Effectiveness of Cross-Tapering Switching to Ziprasidone in Patients with Schizophrenia or Schizoaffective Disorder
por: Na, Kyoungsae, et al.
Publicado: (2016)

Case Report: Ziprasidone induced neuroleptic malignant syndrome
por: Sedhai, Yub Raj, et al.
Publicado: (2021)

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
por: Noda, Yoshihiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e8k7ss157875fv0jfkjbi3ru7g